Hyderabad Telangana, India

Nagaraju Gottumukkala

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mylan Laboratories Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagaraju Gottumukkala. Retrieved from https://idiyas.com/inventor/nagaraju-gottumukkala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nagaraju Gottumukkala: Innovator in Pharmaceutical Chemistry

Introduction

Nagaraju Gottumukkala is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. His work has been recognized for its impact on improving therapeutic options for patients.

Latest Patents

Nagaraju holds a patent for "Polymorphic forms of VENCLEXTA." This patent relates to crystalline forms of venetoclax and the processes for their preparation. Additionally, it covers the process for the preparation of amorphous venetoclax. This innovation is crucial for enhancing the efficacy and stability of the drug.

Career Highlights

Nagaraju is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, where he focuses on creating advanced pharmaceutical solutions. His expertise in polymorphism and drug formulation has positioned him as a valuable asset to his team.

Collaborations

Some of Nagaraju's notable coworkers include Ramakoteswara Rao Jetti and Hemant Malhari Mande. Their collaborative efforts contribute to the innovative environment at Mylan Laboratories Limited, fostering advancements in pharmaceutical research.

Conclusion

Nagaraju Gottumukkala exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of venetoclax formulations, highlight the importance of research and development in improving patient care. His work continues to inspire future advancements in drug formulation and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…